ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,172Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 15

$1.45M Total Retail Price of All Prescriptions

Rank: 2 out of 15

858 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 858 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 858 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 21,165 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 1,231 1,020 1 1
LISINOPRIL 1,083 863 2 4
LACTULOSE 1,056 913 10 3 14
FUROSEMIDE 876 762 4 2
AMLODIPINE BESYLATE 635 541 5 3
NOVOLIN N 558 446 10 6 49
POLYETHYLENE GLYCOL 3350 548 468 7 17
HALOPERIDOL 515 395 8 55
CARVEDILOL 512 389 9 19
METFORMIN HCL 486 328 10 7
RISPERIDONE 473 333 11 28
RANITIDINE HCL 461 356 12 35
SIMVASTATIN 442 294 13 6
POTASSIUM CHLORIDE 433 335 14 10
HYDROCODONE-ACETAMINOPHEN 418 324 S3 15 5
METOPROLOL TARTRATE 411 300 16 9
DIVALPROEX SODIUM 370 208 17 42
KLOR-CON M20 370 325 17 26
QUETIAPINE FUMARATE 323 256 19 20
TAMSULOSIN HCL 282 217 20 31
TRAMADOL HCL 278 219 21 18
PHENYTOIN SODIUM EXTENDED 271 223 22 67
CLONIDINE HCL 271 212 22 32
NORTRIPTYLINE HCL 268 233 24 98
TRAZODONE HCL 267 220 25 27
OMEPRAZOLE 262 177 26 8
LEVETIRACETAM 250 150 27 39
SERTRALINE HCL 239 152 28 22
NAMENDA 227 203 29 12
FINASTERIDE 224 180 30 90
CLOPIDOGREL 222 176 31 30
IPRATROPIUM-ALBUTEROL 204 181 32 89
ISOSORBIDE MONONITRATE ER 201 151 33 61
DONEPEZIL HCL 198 178 34 11
CITALOPRAM HBR 194 144 35 29
WARFARIN SODIUM 193 164 36 13
JANTOVEN 188 159 37 118
BENZTROPINE MESYLATE 187 93 R 38 70
HUMULIN N 186 151 39 106
HYDRALAZINE HCL 181 124 40 66
METOPROLOL SUCCINATE 179 140 41 25
SANTYL 168 146 42 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 162 121 43 58
MIRTAZAPINE 158 145 44 33
LEVOFLOXACIN 155 127 45 76
ESCITALOPRAM OXALATE 147 113 46 16
PLAVIX 146 122 47 43
GLIMEPIRIDE 145 72 48 52
PREDNISONE 145 135 48 62
DILTIAZEM 24HR ER 144 118 50 132
CARBIDOPA-LEVODOPA 143 131 51 64
CYMBALTA 141 118 52 53
ATENOLOL 140 136 53 40
DIGOXIN 140 109 53 46
DIVALPROEX SODIUM ER 137 104 55 133
SEROQUEL 136 102 56 60
CEPHALEXIN 131 124 57 71
DILTIAZEM HCL 130 129 58 138
PROMETHAZINE HCL 122 83 R 59 122
HYDROCHLOROTHIAZIDE 121 70 60 23
OLANZAPINE 121 75 60 47
AGGRENOX 121 110 60 144
PANTOPRAZOLE SODIUM 120 100 63 50
SENSIPAR 120 84 63 146
BUMETANIDE 118 98 65 75
CIPROFLOXACIN HCL 117 99 66 87
DIOVAN 116 90 67 34
NIFEDIPINE ER 114 89 68 122
VALPROIC ACID 113 51 69 111
ALLOPURINOL 112 79 70 57
GABAPENTIN 108 74 71 21
DOXEPIN HCL 106 88 72 119
LATANOPROST 102 102 73 114
ZIPRASIDONE HCL 99 82 74 103
GLIPIZIDE 99 74 74 45
BACLOFEN 98 37 76 102
LANTUS 93 48 77 36
KLOR-CON M10 89 89 78 85
TRIAMTERENE-HCTZ 87 83 79 68
RENVELA 86 38 80 133
KETOCONAZOLE 82 72 81 131
PHENYTOIN 80 72 82 125
DOXAZOSIN MESYLATE 77 56 83 117
TRAVATAN Z 76 61 84 100
PROPRANOLOL HCL 76 74 84 133
FAMOTIDINE 76 75 84 72
AMPICILLIN TRIHYDRATE 74 60 87 177
FOSINOPRIL SODIUM 72 40 88 179
PRAVASTATIN SODIUM 69 55 89 15
MORPHINE SULFATE ER 68 62 S2 90 182
CYCLOBENZAPRINE HCL 68 23 R 90 98
METOCLOPRAMIDE HCL 67 45 92 105
BICALUTAMIDE 64 40 93 188
SPIRONOLACTONE 64 37 93 92
TRIAMCINOLONE ACETONIDE 64 51 93 140
SPIRIVA 63 57 96 83
NITROFURANTOIN 62 59 97 194
DOXYCYCLINE HYCLATE 61 48 98 94
DORZOLAMIDE-TIMOLOL 60 59 99 197
ATORVASTATIN CALCIUM 59 42 100 38
CEFUROXIME 58 48 101 201
CARBAMAZEPINE 57 19 102 203
SPS 57 45 102 203
CYPROHEPTADINE HCL 56 33 R 104 127
ISOSORBIDE DINITRATE 56 49 104 208
FLUTICASONE PROPIONATE 55 39 106 73
CRESTOR 54 38 107 44
PAROXETINE HCL 54 34 107 110
TRIHEXYPHENIDYL HCL 54 31 R 107 210
LITHIUM CARBONATE 52 25 110 212
NEXIUM 52 35 110 24
BRIMONIDINE TARTRATE 52 47 110 155
NOVOLIN R 51 44 113 79
ROPINIROLE HCL 51 51 113 146
OXYBUTYNIN CHLORIDE ER 51 39 113 154
ADVAIR DISKUS 51 36 113 54
MECLIZINE HCL 50 48 117 216
ALENDRONATE SODIUM 50 40 117 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.